Actively Recruiting
A Study to Collect Information About the Use of Redifferentiating Medications as a Standard Treatment for Thyroid Cancer
Led by Memorial Sloan Kettering Cancer Center · Updated on 2026-04-27
100
Participants Needed
1
Research Sites
260 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study to learn more about the use of redifferentiating medications as a standard treatment for radioactive iodine/RAI-refractory thyroid cancer. This study is a registry study.
CONDITIONS
Official Title
A Study to Collect Information About the Use of Redifferentiating Medications as a Standard Treatment for Thyroid Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients 18 years old or older at the time of consent
- Patients diagnosed with radioactive iodine (RAI) refractory thyroid cancer or unlikely to respond to RAI
- Patients who will receive redifferentiation agents before planned diagnostic or therapeutic use of radioactive iodine as part of routine clinical care
- Patients who have never received redifferentiation agents outside of a clinical trial or have received them only in a clinical trial and will now receive them as part of routine care
- Patients previously treated with redifferentiation agents as part of clinical care before radioactive iodine administration who agree to provide retrospective and prospective data
You will not qualify if you...
- Patients with RAI refractory thyroid cancer who will receive redifferentiation agents as part of a prospective clinical trial
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065
Actively Recruiting
Research Team
L
Laura Boucai, MD
CONTACT
A
Alan Ho, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here